Hayley J. Luxton

Robinson Way
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.

The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.

Journal: Molecular cancer

Published: February 22, 2022

Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.

Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.

Journal: Communications biology

Published: October 09, 2020

Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.

Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.

Journal: Communications biology

Published: January 07, 2020

An optimised saliva collection method to produce high-yield, high-quality RNA for translational research.

An optimised saliva collection method to produce high-yield, high-quality RNA for translational research.

Journal: PloS one

Published: July 23, 2019

The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing.

The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing.

Journal: Cancers

Published: July 17, 2019

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.

Journal: Nature genetics

Published: March 06, 2017

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.

Journal: PLoS genetics

Published: February 15, 2017

Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel.

Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel.

Journal: Endocrine-related cancer

Published: August 04, 2016

Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

Journal: Nature genetics

Published: May 29, 2015

The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.

The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.

Journal: European urology

Published: March 23, 2015

HES5 silencing is an early and recurrent change in prostate tumourigenesis.

HES5 silencing is an early and recurrent change in prostate tumourigenesis.

Journal: Endocrine-related cancer

Published: January 07, 2015

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

Journal: Nature genetics

Published: September 29, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026